Jeff B. Smaill
University of Auckland(NZ)Maurice Wilkins Centre(NZ)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Lung Cancer Treatments and Mutations, Cancer Research and Treatments, HER2/EGFR in Cancer Research, Fibroblast Growth Factor Research
Most-Cited Works
- → Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor(1998)417 cited
- → Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor: 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions(2000)263 cited
- → Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor(1999)178 cited
- → The Horner-Wadsworth-Emmons Reaction in Natural Products Synthesis: Expedient Construction of Complex (E)-Enones Using Barium Hydroxide(1993)177 cited
- → Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia(2013)168 cited
- → New Promise and Opportunities for Allosteric Kinase Inhibitors(2019)163 cited